News

Young medical companies with new therapies often navigate a challenging path. That's true today for NovoCure (NASDAQ: NVCR), which makes a wearable device for treating cancer. The average investor

In this video, I will talk about PayPal (NASDAQ: PYPL), especially the recent downgrade it got from MoffettNathanson, and why I believe that the arguments given shouldn't worry investors as these

The stock market has been in recovery mode since the S&P 500 index hit a low on Oct. 12, 2022, with the index rising more than 24% since then thanks to resilient economic growth, cooling inflation

Pfizer (NYSE: PFE) is a stock that everyone's familiar with, but that doesn't mean that everyone agrees you should buy it. While its promise of steady returns and a decent dividend might be

You might remember Luckin Coffee (OTC: LKNC.Y) for all the wrong reasons. In 2019, its former management fabricated $300 million worth of sales, leading to Chapter 15 bankruptcy and delisting from

Equities are unpredictable in the short run. How the market will behave in the next six to 12 months is anyone's guess. However, over more extended periods, of five years or more, things become much

Dividends are a great reason for owning stocks in the long run. These discretionary payouts have the potential to rise over time, thereby giving you an increasing flow of passive income that helps

Initial public offerings (IPOs) are back, and Wall Street couldn't be happier. After 2022's bear market, it took a while for privately held companies to work up the nerve to return to the public

Gene-editing biotechs are hard at work to create the treatments and cures of tomorrow, and any businesses that succeed are likely to be great investments. Of course, it's complicated to figure out

Opera (NASDAQ: OPRA) has been a divisive investment since its IPO in 2018. The bears will note its namesake web browser controls less than 3% of the global market (according to Statcounter), it's

So -- you've got $500 in your pocket and you're looking to invest in some stocks. Great! There's no need to wait until you have several thousand dollars to do so. (Just be sure you're ready to

From Sept. 10 to Sept. 15, Crinetics Pharmaceuticals (NASDAQ: CRNX) stock price gained 83%, and it's still climbing rapidly. The pre-revenue biotech's lead candidate, called paltusotine, reported

It's always hard to wait, and investors are on edge as the Federal Reserve's Open Market Committee begins a two-day meeting on Tuesday to discuss the future path of interest rates. Many market

Realty Income (NYSE: O) for years has been the gold standard when it comes to REITs. The company has generated consistent results based on its in-demand property portfolio, evidenced by a 99%

Atlassian's (NASDAQ: TEAM) stock has rallied nearly 60% this year. Investors turned bullish on the enterprise software company again as its revenue growth stabilized and its operating margins

Many investors have fallen in love with cruise stocks. The sector has crushed the market this year, with companies such as Royal Caribbean Cruises (NYSE: RCL) up around 100% in the last 12 months

More than one survey has found that young people are more optimistic than older people. The Sine Institute's Reimagining the American Dream: Views From Young Americans survey, for example, found

Stocks have rallied sharply this year. The S&P 500 has surged more than 15%, while the Nasdaq 100 has zoomed by nearly 40%. The S&P 500 now trades at more than 20 times forward earnings, while the

It's been a challenging year for banks that have grappled with the highest interest rates we've seen in over 16 years. While higher rates can boost banks' net interest income, the pace of recent